Target intelligence / Profile preview

Ribosomal protein S29 pseudogene 22 (RPS29P22)

Target
RPS29P22
Molecular classification
Other (pseudogene, derived from ribosomal protein S29 gene)
01

Overview

Ribosomal protein S29 pseudogene 22 (RPS29P22) is a genomic sequence in humans that is homologous to the protein-coding gene ribosomal protein S29 (RPS29), but lacks the ability to encode a functional protein due to disabling mutations[1][4][8]. Such pseudogenes typically arise via genomic duplication or retrotransposition events and serve as evolutionary remnants. The parent gene, RPS29, encodes a protein component of the 40S ribosomal subunit, essential for ribosome biogenesis and protein synthesis[3][5]. There is no evidence that RPS29P22 itself is translated or involved directly in any cellular function, nor is it considered a therapeutic target. Some pseudogenes have recently been suggested to exert regulatory effects on gene expression, but no such role is clearly established for RPS29P22[4][8].

Other names
RPS29_6_1530RPS29P22
02

Mechanism of action

None. No drugs target this pseudogene.

03

Biological functions

Pseudogenes like RPS29P22 are generally considered non-functional remnants of evolution without active biological function, though recent research suggests some pseudogenes may have regulatory roles.There is no definitive biological activity attributed to RPS29P22 specifically.
04

Disease associations

None established for RPS29P22 itself. Disease roles are associated with the functional RPS29 gene, not this pseudogene.
05

Safety considerations

None. No known therapeutic challenges related to this pseudogene.

Beyond the preview

Go deeper on Ribosomal protein S29 pseudogene 22 (RPS29P22).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein S29 pseudogene 22 (RPS29P22).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call